Weight and metabolic changes after switching from tenofovir alafenamide/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC+DTG and TDF/FTC/efavirenz (EFV) to TDF/lamivudine /DTG

Simple item page
dc.article.end-page1495en
dc.article.start-page1492en
dc.citation.doi10.1093/CID/CIAC949en
dc.contributor.authorB Boschen
dc.contributor.authorGodspower Akpomiemieen
dc.contributor.authorNomathemba Chandiwanaen
dc.contributor.authorSimiso Sokhelaen
dc.contributor.authorA Hillen
dc.contributor.authorK McCannen
dc.contributor.authorA Qavien
dc.contributor.authorE et alen
dc.contributor.authorWillem Venteren
dc.date.accessioned2024-07-23T05:54:30Z
dc.date.available2024-07-23T05:54:30Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1058-4838en
dc.identifier.urihttps://hdl.handle.net/10539/39057
dc.journal.titleWeight and metabolic changes after switching from tenofovir alafenamide/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC+DTG and TDF/FTC/efavirenz (EFV) to TDF/lamivudine /DTGen
dc.journal.volume76en
dc.publisherOXFORD UNIV PRESS INCen
dc.titleWeight and metabolic changes after switching from tenofovir alafenamide/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC+DTG and TDF/FTC/efavirenz (EFV) to TDF/lamivudine /DTGen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
347.09 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)